A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome

Overview of attention for article published in Frontiers in endocrinology, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 1 users.

International Conference on Children's Bone Health (ICCBH), 17 May 2022

Merz et al: A case report: first long-term treatment with burosumab in a patient with cutaneous-skeletal hypophosphatemia…

International Conference on Children's Bone Health (ICCBH), 12 May 2022

Merz et al: A case report: first long-term treatment with burosumab in a patient with cutaneous-skeletal hypophosphatemia…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.